# Pasithea Therapeutics Corp.: Form 8-K, filed Jan 2, 2024

- Company: [Pasithea Therapeutics Corp.](/companies/ktta.md) (CIK 1841330)
- Form: 8-K
- Filed: 2024-01-02
- Accepted by EDGAR: Jan 2, 2024, 16:47 ET
- Period: 2023-12-29
- Accession: 0001213900-24-000296
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1841330/000121390024000296/ea190803-8k_pasithea.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1841330/000121390024000296/

## Items reported

- Item 3.03: Change to security holders’ rights
- Item 5.03: Amendment to articles or bylaws
- Item 5.07: Shareholder vote results
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1841330/000121390024000296/ea190803-8k_pasithea.htm

Filed Jan 2, 2024.
Source: SEC EDGAR, the filing index for accession 0001213900-24-000296. Last ingested by Listed: Nov 14, 2026, 23:46 ET. No prices; not investment advice.
